Home > List All Publishers > JZMed, Inc.

JZMed, Inc.

JZMed, Inc. is a world leading pharmaceutical outsourcing service provider specializing in a full scale service for pharmaceutical outsourcing in China. It also provides market research services to companies who wish to enter the Chinese pharmaceuticals market or collaborate with Chinese pharmaceutical companies or Chinese pharmaceutical service companies.

List of reports from JZMed, Inc.

Comparison of Biopharmaceutical Industry between China and India 3/1/2013 \| published by: JZMed, Inc. ... untreatable diseases. The fast growth of the global biopharmaceutical market has prompted all global major pharma companies to increase their investment in biopharmaceuticals, which has resulted in a dramatic change in their R&D strategy and ... \| read more...	$4,285.00
China Pharma Outsourcing Market by 2020 1/1/2013 \| published by: JZMed, Inc. ... coupled with other unique features, such as a large pool of talents who possess the desired technical skills and the required service capabilities, has made China one of the most favored destinations around the world ... \| read more...	$4,285.00
Analysis of Top 5 Chinese CROs 12/1/2012 \| published by: JZMed, Inc. ... become as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors ... \| read more...	$1,985.00
Chinese CRO Company Report - Pharmaron 11/1/2012 \| published by: JZMed, Inc. ... become as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors ... \| read more...	$395.00
Chinese CRO Company Report - WuXi PharmaTech 11/1/2012 \| published by: JZMed, Inc. ... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ... \| read more...	$395.00
Chinese CRO Company Report - Tigermed Consulting Co., Ltd. 11/1/2012 \| published by: JZMed, Inc. ... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ... \| read more...	$395.00
Chinese CRO Company Report - ShangPharma 11/1/2012 \| published by: JZMed, Inc. ... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ... \| read more...	$395.00
Chinese CRO Company Report - Beijing Genomic Institute (BGI) 11/1/2012 \| published by: JZMed, Inc. ... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ... \| read more...	$395.00
The New Trends of Drug R&D Outsourcing in China and India 9/1/2012 \| published by: JZMed, Inc. ... in the areas related to drug R&D, which makes each country unique for certain types of drug R&D outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India ... \| read more...	$6,885.00
The New Trends of Drug Discovery Outsourcing in China and India 9/1/2012 \| published by: JZMed, Inc. ... in the areas related to drug R&D, which makes each country unique for certain types of outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India each actually ... \| read more...	$4,285.00
The New Trends of Drug Development Outsourcing in China and India 9/1/2012 \| published by: JZMed, Inc. ... in the areas related to drug R&D, which makes each country unique for certain types of outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India each actually ... \| read more...	$4,285.00
Comparisons of Pharmaceutical Manufacturing between China and India 4/1/2012 \| published by: JZMed, Inc. ... the balances between innovative drugs and generic drugs in their product portfolios and between the developed markets and the emerging markets in their market focuses. As a result, almost all pharma companies have been gradually ... \| read more...	$4,285.00
China Pharma Outsourcing Annual Review 2011 2/1/2012 \| published by: JZMed, Inc. ... this Chinese market has been well in line with our predictions. Prompted by the enormous interest of professionals in a variety of industries in this Chinese market and our obligation to best meet their demand, ... \| read more...	$1,985.00
Outlook of China Drug Formulation Market 5/1/2011 \| published by: JZMed, Inc. ... industry has existed in China for decades and growing numbers of Chinese drug companies are currently focusing on this area, their current technical skills and capability are still limited. However, as the fast growing Chinese ... \| read more...	$3,285.00
China Pharma Outsourcing Annual Review 2010 2/1/2011 \| published by: JZMed, Inc. ... development of this Chinese industry has been well in line with our predictions. Now that the industry has just entered a new year, many organizations and professionals around the world have started wondering again how ... \| read more...	$695.00
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine 1/1/2011 \| published by: JZMed, Inc. ... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ... \| read more...	$3,285.00
Future Outlook of China Preclinical and Toxicology Outsourcing Market 10/1/2010 \| published by: JZMed, Inc. ... that drives up the overall cost of drug discovery effort; whereas the severe toxicity and safety concerns have been the major causes of the high development failure. As all drug companies are vigorously controlling the ... \| read more...	$2,895.00
Chinese Biopharmaceutical Industry: Current State and Future Development 8/1/2010 \| published by: JZMed, Inc. ... are now paying more attention to biologics. Growing numbers of small biopharma companies also focus on discovery and development of novel biologic drugs or niche technologies which are increasingly licensed in by major biopharma companies. ... \| read more...	$2,895.00
China: The Key Pharmemerging Market - Deciphering Major 4/1/2010 \| published by: JZMed, Inc. ... These challenges have forced them to take all necessary actions including reducing the size of their internal R&D organization to increasingly use external resources, increasingly pursuing virtual R&D model by running the internal R&D in ... \| read more...	$1,985.00
The New Trend of API Sourcing and Contract Manufacturing in China 2/1/2010 \| published by: JZMed, Inc. ... have sourced a variety of APIs and pharma intermediates in the country. However, the fast growth of this Chinese industry experienced significant growth slowdown in the last one year or so. The financial crisis, which ... \| read more...	$1,985.00
API Sourcing in China 2/1/2010 \| published by: JZMed, Inc. ... Chinese industry experienced significant growth slowdown in the last one year or so. The financial crisis was only one of the factors to blame. It was, in fact, the severe quality incident in supply chain ... \| read more...	$1,685.00
Innovative Drug R&D in China 10/1/2009 \| published by: JZMed, Inc. ... and improve industry infrastructure. Their programs are infused with increasing numbers of returnees. Their progress is also accelerated by the growing abundance of venture capitals. Their efforts have now started yielding fruitful results. There have ... \| read more...	$2,895.00
Comparison of Pharma Outsourcing between China and India 7/1/2009 \| published by: JZMed, Inc. ... They are now forced to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in R&D or manufacturing. The keys for them to make a quick turnaround are to get drug discovered ... \| read more...	$1,599.00
Top 100 Best Pharma Outsourcing Service Providers in China and India 7/1/2009 \| published by: JZMed, Inc. ... They are now forced to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in R&D or manufacturing. The keys for them to make a quick turnaround are to get drug discovered ... \| read more...	$1,045.00
200 China-based Best CROs and CMOs 3/1/2009 \| published by: JZMed, Inc. ... their drug research, manufacturing and sales work to China, to have a complete collection of information with regards to the current services offered by Chinese service providers and their capabilities in each technical area. To ... \| read more...	$2,248.00

< prev 1 2 next >